A Field Efficacy Trial of Recombinant Porcine Circovirus Type 2d Vaccine in Three Herds
Author:
Ju Lanjeong1, Jayaramaiah Usharani1, Lee Min-A1, Jeong Young-Ju2, You Su-Hwa1, Lee Hyang-Sim1, Hyun Bang-Hun1, Lee Nakhyung2, Kang Seok-Jin1
Affiliation:
1. Division of Viral Diseases, Animal and Plant Quarantine Agency, 177, Gimcheon-si 39660, Gyeongsangbuk-do, Republic of Korea 2. Technology Institute, KBNP, Anyang-si 14059, Gyeonggi-do, Republic of Korea
Abstract
This study aimed to evaluate the efficacy of a virus-like particle (VLP) vaccine containing the open reading frame 2 of porcine circovirus type 2d (PCV2d) in a farm environment where natural infections associated with porcine circovirus-associated disease are endemic. The vaccine trial was conducted on three farms (H, M, and Y) with a history of infections including porcine reproductive and respiratory syndrome virus (PRRSV), PCV, Mycoplasma, and E. coli. Farm H, as well as farms M and Y, experienced natural PCV2 infection between 4 and 8 weeks post-vaccination (wpv), and 8 and 12 wpv, respectively. Viremia levels of all farms were significantly (p < 0.05) lower in vaccinated piglets than the control group after natural infection. In all farms, serum immunoglobulin G levels peaked at 8 wpv in the vaccinated groups, surpassing those in the control groups. Furthermore, neutralizing antibody titers were significantly (p < 0.05) higher in the vaccinated groups than the control groups in farms H and Y (0–8 wpv). However, there were no significant differences between the vaccinated and control group in neutralizing antibody titers of farm M (0–20 wpv). In terms of body weight, vaccinated piglets from all three farms showed significantly increased average weights at 12 wpv compared to the control groups. In conclusion, our study revealed noteworthy differences in viremia and body weight gain between vaccinated and control animals on three farms. As a result, this field trial of PCV2d VLP vaccine was successful in protecting piglets from natural PCV2 infection.
Funder
Animal and Plant Quarantine Agency
Subject
Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology
Reference30 articles.
1. Effect of porcine circovirus type 2 (PCV2) infection on reproduction: Disease, vertical transmission, diagnostics and vaccination;Madson;Anim. Health Res. Rev.,2011 2. Porcine circovirus type 2 (PCV2) infections: Clinical signs, pathology and laboratory diagnosis;Segales;Virus Res.,2012 3. Ouyang, T., Zhang, X., Liu, X., and Ren, L. (2019). Co-Infection of Swine with Porcine Circovirus Type 2 and Other Swine Viruses. Viruses, 11. 4. Song, S., Park, G.N., Choe, S., Cha, R.M., Kim, S.Y., Hyun, B.H., Park, B.K., and An, D.J. (2020). Genetic Diversity of Porcine Circovirus Isolated from Korean Wild Boars. Pathogens, 9. 5. PCR detection of porcine circovirus type 2 (PCV2) DNA in blood, tonsillar and faecal swabs from experimentally infected pigs;Caprioli;Res. Vet. Sci.,2006
|
|